Greenlight Capital's Q2 Trades: New Positions in FLR, VSCO, and Exit from VTRS
PorAinvest
jueves, 14 de agosto de 2025, 12:14 pm ET1 min de lectura
FLR--
Greenlight Capital acquired 760.6K shares of Fluor and 168.3K shares of Victoria's Secret during the second quarter of 2025, according to the latest 13F filing [1]. The firm also sold its entire position in Varex Imaging, which had been part of its portfolio. Other significant trades include increasing its stake in Albireo Pharma and Amgen, and reducing its holdings in Activision Blizzard and Bristol Myers Squibb.
Separately, the SEC filing form 4 reveals that Thomas James Curnock, the Group Chief Underwriting Officer at Greenlight Capital Re, Ltd., sold 11,500 ordinary shares on August 8, 2025, at a price of $12.9345 per share, totaling $148,746 [2].
These moves by Greenlight Capital reflect the hedge fund's strategy and positioning in various sectors. Investors should closely monitor these developments to understand the fund's approach and potential future investments.
References:
[1] https://seekingalpha.com/news/4485554-david-einhorns-greenlight-capital-adds-flr-vsco-exits-vtrs-among-other-trades
[2] https://www.tradingview.com/news/tradingview:0ce9c15714637:0-greenlight-capital-re-executive-sells-shares/
VSCO--
David Einhorn's Greenlight Capital has disclosed its Q2 2025 13F filing, revealing new positions in Fluor (760.6K shares) and Victoria's Secret (168.3K shares). The hedge fund also exited its position in Varex Imaging (VTRS). Other notable trades include adding to existing positions in Albireo Pharma (ABIO), Amgen (AMGN), and reducing holdings in Activision Blizzard (ATVI) and Bristol Myers Squibb (BMY).
David Einhorn's Greenlight Capital has released its Q2 2025 13F filing, providing insights into the hedge fund's latest investment activities. The filing indicates that Greenlight Capital has taken new positions in Fluor (NYSE:FLR) and Victoria's Secret (NYSE:VSCO), while also exiting its position in Varex Imaging (VTRS). Additionally, the fund has made other notable trades, including adding to existing positions in Albireo Pharma (ABIO), Amgen (AMGN), and reducing holdings in Activision Blizzard (ATVI) and Bristol Myers Squibb (BMY).Greenlight Capital acquired 760.6K shares of Fluor and 168.3K shares of Victoria's Secret during the second quarter of 2025, according to the latest 13F filing [1]. The firm also sold its entire position in Varex Imaging, which had been part of its portfolio. Other significant trades include increasing its stake in Albireo Pharma and Amgen, and reducing its holdings in Activision Blizzard and Bristol Myers Squibb.
Separately, the SEC filing form 4 reveals that Thomas James Curnock, the Group Chief Underwriting Officer at Greenlight Capital Re, Ltd., sold 11,500 ordinary shares on August 8, 2025, at a price of $12.9345 per share, totaling $148,746 [2].
These moves by Greenlight Capital reflect the hedge fund's strategy and positioning in various sectors. Investors should closely monitor these developments to understand the fund's approach and potential future investments.
References:
[1] https://seekingalpha.com/news/4485554-david-einhorns-greenlight-capital-adds-flr-vsco-exits-vtrs-among-other-trades
[2] https://www.tradingview.com/news/tradingview:0ce9c15714637:0-greenlight-capital-re-executive-sells-shares/

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios